Published in Elife on October 18, 2016
Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease. Proc Natl Acad Sci U S A (2017) 0.75
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol (2007) 17.69
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet (2004) 14.31
Adapting proteostasis for disease intervention. Science (2008) 13.22
Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem (1991) 12.68
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell (1996) 12.59
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature (2004) 11.82
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science (1997) 11.53
Protein aggregation and neurodegenerative disease. Nat Med (2004) 9.51
Trinucleotide repeat disorders. Annu Rev Neurosci (2007) 9.45
Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol (2000) 9.40
Molecular chaperones in protein folding and proteostasis. Nature (2011) 8.63
Huntington disease. J Neuropathol Exp Neurol (1998) 6.54
Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol (1999) 5.89
Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol (2007) 5.78
Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov (2012) 5.26
The physical basis of how prion conformations determine strain phenotypes. Nature (2006) 4.77
Misfolded proteins partition between two distinct quality control compartments. Nature (2008) 4.75
Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc Natl Acad Sci U S A (1999) 4.58
Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat Neurosci (2010) 4.22
Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue. Cell (2013) 4.02
Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell (2011) 3.98
Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell (2009) 3.95
SUMO modification of Huntingtin and Huntington's disease pathology. Science (2004) 3.85
Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell (2001) 3.41
Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet (1996) 3.08
Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol (2009) 2.77
Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol (1999) 2.65
Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc Natl Acad Sci U S A (2006) 2.59
The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat Cell Biol (2006) 2.58
A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol (2010) 2.48
Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol (2014) 2.48
Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron (2009) 2.43
Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat Cell Biol (2006) 2.37
A toxic monomeric conformer of the polyglutamine protein. Nat Struct Mol Biol (2007) 2.33
Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. Biochim Biophys Acta (2008) 2.29
Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci (2010) 2.29
Translation elongation factor EF-P alleviates ribosome stalling at polyproline stretches. Science (2012) 2.28
Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol (2011) 2.24
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A (2013) 2.21
Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol Cell (2006) 2.16
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol (2009) 2.16
Oligoproline effects on polyglutamine conformation and aggregation. J Mol Biol (2005) 2.14
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem (2010) 2.10
Aging as an event of proteostasis collapse. Cold Spring Harb Perspect Biol (2011) 2.06
Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J Neurosci (2002) 2.05
eIF5A promotes translation of polyproline motifs. Mol Cell (2013) 2.04
The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation. Nat Struct Mol Biol (2009) 1.98
Kinase inhibitors modulate huntingtin cell localization and toxicity. Nat Chem Biol (2011) 1.97
The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet (2006) 1.96
Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc Natl Acad Sci U S A (2009) 1.96
Huntington aggregates may not predict neuronal death in Huntington's disease. Ann Neurol (1999) 1.91
Neuronal transfection in brain slices using particle-mediated gene transfer. Neuron (1994) 1.87
Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci U S A (2005) 1.87
Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins. Cell (2010) 1.76
Conformation-dependent anti-amyloid oligomer antibodies. Methods Enzymol (2006) 1.72
Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J Neurosci (2004) 1.64
A linear lattice model for polyglutamine in CAG-expansion diseases. Proc Natl Acad Sci U S A (2002) 1.62
Flanking polyproline sequences inhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helix structure. J Mol Biol (2007) 1.59
polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc Natl Acad Sci U S A (2005) 1.57
Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease. J Neurochem (2007) 1.54
Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Nat Chem Biol (2013) 1.52
The nascent polypeptide-associated complex is a key regulator of proteostasis. EMBO J (2013) 1.40
Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation. Proc Natl Acad Sci U S A (2013) 1.39
Huntingtin functions as a scaffold for selective macroautophagy. Nat Cell Biol (2015) 1.39
Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin. J Mol Biol (2009) 1.30
Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J Neurosci Res (1998) 1.29
Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates. Biochem Biophys Res Commun (2000) 1.20
Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J Mol Biol (2011) 1.17
A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Cell Rep (2014) 1.17
Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation. Proc Natl Acad Sci U S A (2015) 1.15
Using antibodies to analyze polyglutamine stretches. Methods Mol Biol (2004) 1.14
The huntingtin N17 domain is a multifunctional CRM1 and Ran-dependent nuclear and cilial export signal. Hum Mol Genet (2013) 1.07
Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein. J Biol Chem (2012) 1.07
Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin. Proc Natl Acad Sci U S A (2013) 1.06
Structural features and domain organization of huntingtin fibrils. J Biol Chem (2012) 1.04
Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain. Nat Commun (2015) 1.03
TRiC's tricks inhibit huntingtin aggregation. Elife (2013) 1.02
Disease-associated polyglutamine stretches in monomeric huntingtin adopt a compact structure. J Mol Biol (2012) 0.99
An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1. J Biol Chem (2013) 0.99
Mechanism of cis-inhibition of polyQ fibrillation by polyP: PPII oligomers and the hydrophobic effect. Biophys J (2009) 0.95
Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties. Biochemistry (2012) 0.94
Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypes. Proc Natl Acad Sci U S A (2013) 0.93
Trinucleotide repeats: a structural perspective. Front Neurol (2013) 0.89
Detection of Mutant Huntingtin Aggregation Conformers and Modulation of SDS-Soluble Fibrillar Oligomers by Small Molecules. J Huntingtons Dis (2012) 0.89
Role of the coiled-coil structural motif in polyglutamine aggregation. Biochemistry (2014) 0.87
CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease. Hum Mol Genet (2010) 0.86
Structural Mechanisms of Mutant Huntingtin Aggregation Suppression by the Synthetic Chaperonin-like CCT5 Complex Explained by Cryoelectron Tomography. J Biol Chem (2015) 0.86
Live cell imaging and biophotonic methods reveal two types of mutant huntingtin inclusions. Hum Mol Genet (2013) 0.84
Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils. Biochemistry (2015) 0.83
N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice. Neuron (2015) 0.83
Influence of gold nanoparticles on the kinetics of α-synuclein aggregation. Nano Lett (2013) 0.82
Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay. Neurobiol Dis (2011) 0.82
Super-resolution fluorescence of huntingtin reveals growth of globular species into short fibers and coexistence of distinct aggregates. ACS Chem Biol (2014) 0.81
Autoinhibitory structure of the WW domain of HYPB/SETD2 regulates its interaction with the proline-rich region of huntingtin. Structure (2014) 0.81
Anti-PolyQ Antibodies Recognize a Short PolyQ Stretch in Both Normal and Mutant Huntingtin Exon 1. J Mol Biol (2015) 0.79
Delayed emergence of subdiffraction-sized mutant huntingtin fibrils following inclusion body formation. Q Rev Biophys (2015) 0.78
Soluble Oligomers of PolyQ-Expanded Huntingtin Target a Multiplicity of Key Cellular Factors. Mol Cell (2016) 0.76
Conformational switch of polyglutamine-expanded huntingtin into benign aggregates leads to neuroprotective effect. Sci Rep (2015) 0.76
Multivalent contacts of the Hsp70 Ssb contribute to its architecture on ribosomes and nascent chain interaction. Nat Commun (2016) 0.75
An information theoretic framework reveals a tunable allosteric network in group II chaperonins. Nat Struct Mol Biol (2017) 0.75